Global Gene Editing Technology Market Size, Status and Forecast 2021-2027

SKU ID : QYR- 17703761

Publishing Date : 17-Mar-2021

No. of pages : 106

PRICE
3900
5850
7800

  • Gene editing is a new and accurate genetic engineering technology that can modify specific target genes in the genome of an organism.
    Gene editing technology refers to the ability for humans to "edit" targeted genes to achieve modifications to specific DNA fragments.
    Gene editing relies on genetically engineered nucleases, also known as "molecular scissors," to produce site-specific double-strand breaks (DSBs) at specific locations in the genome, inducing organisms to connect via non-homologous end junctions (NHEJ) or homologous Source Recombination (HR) to repair DSB because this repair process is error-prone, resulting in targeted mutations

    In 2021, the global Gene Editing Technology market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
    This report focuses on the global Gene Editing Technology status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Gene Editing Technology development in North America, Europe, Japan, China, Southeast Asia, India, etc.

    Global Gene Editing Technology Scope and Market Size
    Gene Editing Technology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Editing Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Homologous Recombination
    Meganuclease

    Segment by Application
    Agriculture
    Medical
    Other

    By Region
    North America
    Europe
    Japan
    China
    Southeast Asia
    India

    By Company
    Thermo Fisher Scientific
    SIGMA ALDRICH
    Dharmacon
    Cellectics
    CRISPR Therapeutics
    AstraZeneca
    Bio Rad
    Allele Biotech
    Recombinetics
    Lonza
    GE Healthcare
    Editas Medicine
    Agilent Technologies
    QIAGEN NV

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports